InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by File Justin J., Chief Financial Officer. Officer active across 2 companies, notably Evofem Biosciences, Inc.. In total, 5 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €34k. History available since 20 May 2021. The latest transaction was filed on 18 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to File Justin J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
450,000 shares0Common StockSEC:0001618835-22-000030:0
120,000 shares0Common StockSEC:0001618835-22-000005:0
40,594 shares@ US$0.3720.9% of flowCommon StockSEC:0001618835-21-000272:0
Canonical exit: 20 Mar 2022 (T+90)
24,500 shares@ US$1.0332.5% of flowCommon StockSEC:0001618835-21-000148:0
Canonical exit: 8 Sept 2021 (T+90)
42,280 shares@ US$0.8646.6% of flowCommon StockSEC:0001618835-21-000134:0
5 of 5 declarations
About File Justin J.
Justin J. File is the Chief Financial Officer at Evofem Biosciences, Inc. In this role, he is responsible for managing the company's finances, including financial planning and performance analysis. Justin plays a key role in preparing financial reports and managing financial risks.
